Undergoing a stem cell transplant is a brave and life-changing step. Once the transplant is over, the real work of recovery begins—especially when it comes to hidden threats like cytomegalovirus (CMV).
For patients with weakened immune systems, such as those who have had an allogeneic hematopoietic stem cell transplant (HSCT), CMV can quietly reactivate and cause serious health problems. That’s why LuciLeter 240 mg, developed by Lucius Pharmaceuticals, was created to help.
What Is LuciLeter?
- A trusted antiviral medication designed for daily use during transplant recovery.
- Made by Lucius Pharmaceuticals in Vientiane, Laos, helping transplant patients stay protected against CMV.
- More than just treatment—it’s a proactive way to protect healing families, restful nights, and steps toward wellness.
How LuciLeter Works
Recovery after transplant is like rebuilding a garden—your immune system needs time and protection. CMV, which may hide quietly in your body, can suddenly reactivate when your defenses are low.
LuciLeter works by targeting a critical step in the CMV life cycle. Instead of killing the virus outright, it blocks a key viral “assembly line” called the terminase complex. Without it, the virus can’t finish making new copies and spread—meaning no new infection and no new cells getting infected.


Why It Matters During Recovery
- Prevents serious complications: CMV can cause pneumonia, gastrointestinal problems, or even transplant rejection.
- Silent but dangerous: CMV can reactivate before symptoms appear, so early protection is essential.
- Taken proactively: Letermovir 240mg tablets are used even when no symptoms are present, acting as a silent guardian in the background.

Designed with Your Well‑Being in Mind
- Highly selective: Letermovir tablets blocks a virus-specific function without harming your healthy cells or overworking your immune system.
- Fewer side effects: Compared to older antivirals, it’s easier to tolerate during recovery.
- Globally trusted ingredient: Contains letermovir, a clinically proven antiviral.
- Expanded access: Lucius Pharmaceuticals makes this important medicine available in Southeast Asia and beyond.
Why Letermovir 240mg Makes a Difference
- For doctors and caregivers: It allows them to focus on supporting your immune system without worrying about CMV reactivation.
- For patients and families: It brings reassurance, knowing there’s a safety net protecting each step of your recovery.
With LuciLeter 240 mg, every patient recovering from a stem cell transplant can have stronger protection and greater peace of mind. Because in this journey, every moment matters—and every life deserves to feel safe again.




